AI nanobody design, from sequence to candidate.
Tools and therapeutic programs built on a single in-house pipeline: scGPT target discovery, AlphaFold 3 validation, and molecular dynamics — open to academia, partnerable for industry.
Built in Spain · Live products · Open API · Patent filed
Three products. One platform.
Free tools for academics, paid SaaS for biotechs, partnerable therapeutic pipeline for pharma.
ImmunoCheck
Free antibody developability API
MHC-II immunogenicity, humanization scoring, developability profiling — instantly, for any antibody sequence. No key, no signup.
NanobodyAI
End-to-end VHH design SaaS
From target sequence to 10 ranked candidates in 45 minutes. AlphaFold 3, ESMFold, developability scoring and codon-optimized DNA — all included.
JFIN-0007-G2
Anti-CD74 nanobody for Multiple Sclerosis
Lead therapeutic asset: a 121 aa VHH blocking the MIF binding site on CD74. Currently in in silico validation, pre-production.
Contact
Let's talk
Whether you're a biotech, pharma BD, investor, academic group or just curious — drop us a line.
info@jfinnova.es
contact.location
Madrid, Spain
contact.ndaDescription